Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | PTGX | ALKS | ||
| Company | Spyre Therapeutics Inc | Protagonist Therapeutics Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 101.02 | 141.79 | 52.96 | ||
| High | 102.92 | 143.29 | 53.24 | ||
| Low | 100.49 | 139.47 | 52.71 | ||
| Latest | 101.52 | 141.91 | 52.58 | ||
| Change | +1.29 | +1.00 | -0.14 | ||
| % Change | +1.29% | +0.71% | -0.27% | ||
| Volume | 50,484 | 25,813 | 34,967 | ||
| 20-Day Average Volume | 1,801,535 | 894,274 | 2,320,002 | ||
| Previous Close | 100.23 | 140.91 | 52.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.02 | 129.61 | 52.35 | ||
| 20-Day Raw Stochastic | 86.05% | 88.14% | 73.61% | ||
| 20-Day Relative Strength | 61.88 | 66.30 | 65.32 | ||
| Weighted Alpha | +405.11 | +136.29 | +113.99 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.63% since 07/13/26 | +7.38% since 07/13/26 | +1.90% since 07/13/26 | ||
| Low | 92.37 on 07/17/26 | 126.97 on 07/15/26 | 50.49 on 07/15/26 | ||
| High | 105.09 on 07/14/26 | 143.00 on 07/20/26 | 53.51 on 07/16/26 | ||
| 1-Month | |||||
| %Chg | +15.26% since 06/18/26 | +23.58% since 06/18/26 | +17.48% since 06/18/26 | ||
| Low | 81.65 on 06/24/26 | 113.24 on 06/22/26 | 45.01 on 06/22/26 | ||
| High | 105.09 on 07/14/26 | 143.00 on 07/20/26 | 55.67 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +38.74% since 04/20/26 | +32.24% since 04/20/26 | +54.41% since 04/20/26 | ||
| Low | 64.67 on 05/19/26 | 92.75 on 06/02/26 | 32.83 on 04/27/26 | ||
| High | 105.09 on 07/14/26 | 143.00 on 07/20/26 | 55.67 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +201.87% since 01/20/26 | +67.19% since 01/20/26 | +66.47% since 01/20/26 | ||
| Low | 30.92 on 02/04/26 | 77.00 on 02/23/26 | 27.00 on 03/19/26 | ||
| High | 105.09 on 07/14/26 | 143.00 on 07/20/26 | 55.67 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,813,824 | 9,062,062 | 8,787,159 | ||
| Shares Outstanding, K | 87,936 | 64,311 | 166,676 | ||
| Annual Sales | 0 | 46,020,000 | 1,475,900,000 | ||
| Annual Net Income | -155,200,000 | -130,150,000 | 241,660,000 | ||
| Last Quarter Sales | 0 | 56,370,000 | 392,910,000 | ||
| Last Quarter Net Income | -69,010,000 | 3,780,000 | -66,480,000 | ||
| 60-Month Beta | 3.02 | 1.79 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/05/26 | 0.05 on 05/05/26 | -0.40 on 05/05/26 | ||
| Earnings Date | 08/04/26 | 08/05/26 | 07/28/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 54.67 | ||